$25.17
0.36% yesterday
Nasdaq, Jun 26, 10:00 pm CET
ISIN
US6807101000
Symbol
OLK

Olink Holding AB (publ) - ADR Share price

$25.17
+1.20 5.01% 1M
-0.01 0.04% 6M
+0.02 0.08% YTD
+7.95 46.17% 1Y
-9.83 28.09% 3Y
+5.17 25.85% 5Y
+5.17 25.85% 10Y
Nasdaq, Closing price Wed, Jun 26 2024
ISIN
US6807101000
Symbol
OLK
Sector
Industry

Key figures

Market capitalization $3.13b
Enterprise Value $3.05b
PER (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 17.78
P/S ratio (TTM) P/S ratio 18.27
P/B ratio (TTM) P/B ratio 6.78
Sales growth (TTM) Sales growth 18.74%
Turnover (TTM) Turnover $171.34m
EBIT (operating result TTM) EBIT $-58.84m
Free cash flow (TTM) Free cash flow $-59.74m
Cash position $109.28m
EPS (TTM) EPS $-0.27
P/E ratio expected negative
P/S ratio expected 15.68
EV/Sales expected 15.26
Short interest 6.84%
Show more

Is Olink Holding AB (publ) - ADR a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,947 shares worldwide.

Olink Holding AB (publ) - ADR Share analysis

Unlock scores for free

Analyst opinions

4 Analysts have issued a Olink Holding AB (publ) - ADR forecast:

4x Hold
100%

Analyst opinions

4 Analysts have issued a Olink Holding AB (publ) - ADR forecast:

Hold
100%

Financial data from Olink Holding AB (publ) - ADR

Profit and loss account P&L | Balance sheet | Cash flow


Quarter TTM Annually
Mar '24
+/-
%
171 171
19% 19%
100%
- Direct costs 57 57
24% 24%
33%
115 115
16% 16%
67%
- Selling and administrative expenses 115 115
34% 34%
67%
- Research and development costs 38 38
44% 44%
22%
-39 -39
176% 176%
-23%
- Depreciation and amortization 20 20
17% 17%
12%
EBIT (operating result) EBIT -59 -59
88% 88%
-34%
Net profit -34 -34
130% 130%
-20%

Figures in millions USD.

Don't miss a thing! We will send you all news about the Olink Holding AB (publ) - ADR share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Olink Holding AB (publ) - ADR Share News

Neutral
GlobeNewsWire
16 days ago
This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.
Neutral
GlobeNewsWire
21 days ago
UPPSALA, Sweden, June 06, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink Target 48 Immune Surveillance, a validated multiplexed protein assay panel that offers a detailed view of the immune system for in-depth monitoring of inflammation and immune response in clinical research.
Neutral
Seeking Alpha
about one month ago
Lab Instrument and Services providers in the healthcare industry can generate high recurring revenues. Many loss-making instrument makers in the industry may not provide meaningful returns and carry high risks. Cytek stands out as the best opportunity in the sector due to strong growth and manageable losses.
More Olink Holding AB (publ) - ADR News

Company profile

Olink Holding AB engages in developing and expanding its platform of immunoassay panels for protein biomarker discovery. It enables and accelerates the field of proteomics by providing a platform of products and services, developed with key opinion leaders (KOLs), that are deployed across biopharmaceutical companies. The company was founded on December 13, 2018 and is headquartered in Uppsala, Sweden.

Head office Sweden
CEO Jon Heimer
Employees 707
Founded 2019
Website www.olink.com

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now